A proteomic primer for the clinician.
Yurong Guo1, Zongming Fu, Jennifer E Van Eyk
1Department of Medicine, The Johns Hopkins University, Baltimore, Maryland 21224, USA. yguo7@jhmi.edu
Proceedings of the American Thoracic Society
|January 5, 2007
Summary
Proteomics accelerates medical discoveries by identifying drug targets and disease biomarkers. This review covers key technologies for protein analysis, aiding in diagnostics and understanding biological interactions.
Area of Science:
- Life Sciences
- Medical Research
- Biotechnology
Background:
- Proteomics is a rapidly advancing field with significant implications for life sciences and medicine.
- It offers potential for discovering novel drug targets and protein-based biomarkers for in vitro diagnostics.
- Understanding protein functions and interactions is crucial for biological and medical research.
Purpose of the Study:
- To review current proteomics technologies for biomarker discovery and validation.
- To discuss strategies for analyzing protein-protein interactions and post-translational modifications.
- To highlight the importance of selecting appropriate technologies for data interpretation.
Main Methods:
- Review of established proteomics techniques including two-dimensional gel electrophoresis.
- Overview of chromatographic methods such as one- and two-dimensional liquid chromatography.
- Discussion of proteomic microarrays and their applications.
Main Results:
- The reviewed technologies provide diverse approaches for comprehensive proteomic analysis.
- Different methods are suited for specific applications like biomarker identification or interaction studies.
- Effective data interpretation relies on the strategic selection and combination of technologies.
Conclusions:
- Proteomics technologies are vital tools for advancing medical research and diagnostics.
- The choice of technology significantly impacts the utility and interpretability of proteomic data.
- Further integration and optimization of proteomics methods will enhance biomarker discovery and understanding of disease mechanisms.

